Could a back injection ease the need for life support in pancreatitis?

NCT ID NCT07697690

Not yet recruiting Symptom relief Sponsor: First People's Hospital of Chenzhou Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study tests whether a thoracic epidural block—a numbing injection near the spine—can help people with severe acute pancreatitis avoid or shorten the need for intensive care support like breathing machines and kidney dialysis. Participants are randomly assigned to receive either the epidural block with ropivacaine or standard pain relief. The main goal is to see if the block increases the number of days patients are alive and free from organ support during the first two weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Thoracic epidural block with ropivacaine
What this could lead to: If effective, this pain-blocking technique could reduce the need for breathing machines, kidney support, and strong painkillers in severe pancreatitis patients.
What could go wrong: This is a single-center trial with 120 participants, so results may not apply broadly. The epidural procedure carries risks like bleeding, infection, or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS (AP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute necrotizing pancreatitis acute pancreatitis pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE PANCREATITIS (AP) ORGAN DYSFUNCTION ORGAN SUPPORT SEVERE ACUTE PANCREATITIS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.